1,128
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Adaptation of a microbead assay for the easy evaluation of traditional anti-sickling medicines: application to DREPANOSTAT and FACA

, , , , , & show all
Pages 385-392 | Received 07 Mar 2018, Accepted 14 Jul 2018, Published online: 28 Sep 2018

References

  • Abu S, Anyaibe S, Headings V. 1981. Chromatographic fractionation of anti-sickling agents in Fagara xanthoxyloides. Acta Haematol. 66:19–26.
  • Ameh SJ, Tarfa FD, Ebeshi BU. 2012. Traditional herbal management of sickle cell anemia: lessons from Nigeria. Anemia. 2012:607436.
  • Brandow AM, Panepinto JA. 2010. Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities. Expert Rev Hematol. 3:255–260.
  • Carboni C. 2009. La drepanocytose au Senegal: un exemple de medecine traditionnelle. [Drepanocytosis in Senegal: an example of traditional medicine]. Sci Pharma. 184 pages. French.
  • Chaaib Kouri F. Investigation phytochimique d’une brosse à dents africaine ‘Zanthoxylum zanthoxyloides’ (Lam.) Zepernick et Timler (Syn. ‘Fagara zanthoxiloides’ L.) (Rutaceae). Ph.D. 2004, Lausanne.
  • Haddad M, Laurens V, Lacaille-Dubois M-A. 2004. Induction of apoptosis in a leukemia cell line by triterpene saponins from Albizia adianthifolia. Bioorg Med Chem. 12:4725–4734.
  • Lee C-C, Lin Y-H, Chang W-H, Wu Y-C, Chang J-G. 2012. The small molecule calactin induces DNA damage and apoptosis in human leukemia cells. Eur J Cancer Prev. 21:467–473.
  • Mannino RG, Myers DR, Ahn B, Wang Y, Margo Rollins Gole H, Lin AS, Guldberg RE, Giddens DP, Timmins LH, Lam WA. 2015. Do-it-yourself in vitro vasculature that recapitulates in vivo geometries for investigating endothelial-blood cell interactions. Sci Rep. 5:12401–12413.
  • Matu EN. 2011. Zanthoxylum zanthoxyloides (PROTA) — PlantUse [WWW Document]. [accessed 2017 May 16]. http://uses.plantnet-project.org/fr/Zanthoxylum_zanthoxyloides_(PROTA)
  • Moonen JR, Lee ES, Schmidt M, Maleszewska M, Koerts JA, Brouwer LA, van Kooten TG, van Luyn MJ, Zeebregts CJ, Krenning G, et al. 2015. Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress. Cardiovasc Res. 108:377–386.
  • Mpiana PT, Ngbolua KNN, Bokota MT, Kasonga TK, Atibu EK, Tshibangu DST, Mudogo V. 2010. In vitro effects of anthocyanin extracts from Justicia secunda Vahl on the solubility of haemoglobin S and membrane stability of sickle erythrocytes. Blood Transfus. 8:248–254.
  • Mpiana PT, Tshibangu DST, Shetonde OM, Ngbolua KN. 2007. In vitro antidrepanocytary actvity (anti-sickle cell anemia) of some Congolese plants. Phytomedicine. 14:192–195.
  • Nurain IO, Bewaji CO, Johnson JS, Davenport RD, Zhang Y. 2017. Potential of three ethnomedicinal plants as antisickling agents. Mol Pharm. 14:172–182.
  • Ouattara B, Angenot L, Guissou P, Fondu P, Dubois J, Frédérich M, Jansen O, van Heugen JC, Wauters JN, Tits M. 2004. LC/MS/NMR analysis of isomeric divanilloylquinic acids from the root bark of Fagara zanthoxyloides Lam. Phytochemistry. 65:1145–1151.
  • Ouattara B, Jansen O, Angenot L, Guissou IP, Frédérich M, Fondu P, Tits M. 2009. Antisickling properties of divanilloylquinic acids isolated from Fagara zanthoxyloides Lam. (Rutaceae). Phytomedicine. 16:125–129.
  • Ouedraogo S, Traore A, Lompo M, Some N, Sana B, Guissou IP. 2011. Vasodilator effect of Zanthoxylum zanthoxyloïdes, Calotropis procera and FACA, a mixture of these two plants. Int J Biol Chem Sci. 5:1351–1357.
  • Pais E, Cambridge JS, Johnson CS, Meiselman HJ, Fisher TC, Alexy T. 2009. A novel high-throughput screening assay for sickle cell disease drug discovery. J Biomol Screen. 14:330–336.
  • Pascual A, Basco LK, Baret E, Amalvict R, Travers D, Rogier C, Pradines B. 2011. Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs. Malar J. 10:8.
  • Pauline N, Cabral BNP, Anatole PC, Jocelyne AMV, Bruno M, Jeanne NY. 2013. The in vitro antisickling and antioxidant effects of aqueous extracts Zanthoxyllum heitzii on sickle cell disorder. BMC Complement Altern Med. 13:162–169.
  • Piel FB, Steinberg MH, Rees DC. 2017. Sickle cell disease. N Engl J Med. 376:1561–1573.
  • Pousset JL. 2006. Place des medicaments traditionnels en Afrique [The place of traditional medicines in Africa]. Médecine Trop. 66:606–609.
  • Queiroz EF, Hay AE, Chaaib F, Diemen D, van Diallo D, Hostettmann K. 2006. New and bioactive aromatic compounds from Zanthoxylum zanthoxyloides. Planta Med. 72:746–750.
  • Schindelin J, Rueden CT, Hiner MC, Eliceiri KW. 2015. The ImageJ ecosystem: an open platform for biomedical image analysis. Mol Reprod Dev. 82:518–529.
  • Tsugawa H, Cajka T, Kind T, Ma Y, Higgins B, Ikeda K, Kanazawa M, Vander Gheynst J, Fiehn O, Arita M. 2015. MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat Methods. 12:523–526.
  • Tsugawa H, Kind T, Nakabayashi R, Yukihira D, Tanaka W, Cajka T, Saito K, Fiehn O, Arita M. 2016. Hydrogen rearrangement rules: computational MS/MS fragmentation and structure elucidation using MS-FINDER software. Anal Chem. 88:7946–7958.
  • Wambebe CO, Bamgboye EA, Badru BO, Khamofu H, Momoh JA, Ekpeyong M, Audu BS, Njoku SO, Nasipuri NR, Kunle OO, et al. 2001. Efficacy of niprisan in the prophylactic management of patients with sickle cell disease. Curr Ther Res. 62:26–34.
  • World Health Organization (WHO). Sickle-cell disease and other haemoglobin disorders. 2011. [accessed 2017 May 4]. http://www.who.int/mediacentre/factsheets/fs308/en/